سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - mometasoni-17 furoas - dosier nasenspray - mometasoni-17 furoas monohydricus 0.5173 mg, benzalkonii chloridum 0.20 mg, glycerolum, polysorbatum 80, cellulosum microcristallinum et carmellosum natricum, acidum citricum monohydricum, natrii citras anhydricus, aqua purificata ad suspensionem pro 1 g corresp. mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140. - rinite, nasenpolypen - synthetika

سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - azelastini hydrochloridum, fluticasoni propionas - sospensione - azelastini hydrochloridum 0.137 mg, fluticasoni propionas 0.05 mg, glycerolum, cellulosum microcristallinum et carmellosum natricum, dinatrii edetas, polysorbatum 80, benzalkonii chloridum 0.014 mg, alcohol phenylethylicus, aqua purificata, ad suspensionem pro dosi, doses pro vase 120. - symptomatische behandlung der saisonalen allergischen rhinitis und rhinokonjunktivitis. - synthetika

إيطاليا - الإيطالية - Ministero della Salute

wolfe tory medical, inc. - sistemi di nebulizzazione a freddo

إيطاليا - الإيطالية - Ministero della Salute

wolfe tory medical, inc. - sistemi di nebulizzazione a freddo

سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - mometasoni-17 furoas - sospensione - mometasoni-17 furoas 0.5 mg ut mometasoni-17 furoas monohydricus, benzalkonii chloridum 0.2 mg, glycerolum, polysorbatum 80, cellulosum microcristallinum, carmellosum natricum, acidum citricum monohydricum, natrii citras anhydricus, aqua purificata ad suspensionem pro 1 g corresp., mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140. - rinite, nasenpolypen - synthetika